These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36048564)

  • 1. Pharmacological Management of Inflammatory Bowel Disease: a Century of Expert Opinions in Cecil Textbook of Medicine.
    Manu P; Rogozea LM; Dumitraşcu DL
    Am J Ther; 2022 Sep-Oct 01; 29(5):e500-e506. PubMed ID: 36048564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Escalation Assessment Among Targeted Immunomodulators in the Management of Inflammatory Bowel Disease.
    Ehrenberg R; Griffith J; Theigs C; McDonald B
    J Manag Care Spec Pharm; 2020 Jun; 26(6):758-765. PubMed ID: 32191593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.
    Ben-Horin S; Novack L; Mao R; Guo J; Zhao Y; Sergienko R; Zhang J; Kobayashi T; Hibi T; Chowers Y; Peyrin-Biroulet L; Colombel JF; Kaplan GG; Chen MH
    Gastroenterology; 2022 Feb; 162(2):482-494. PubMed ID: 34757139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2023 Jul; 65(1680):105-112. PubMed ID: 37418329
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel targets for inflammatory bowel disease therapeutics.
    Löwenberg M; D'Haens G
    Curr Gastroenterol Rep; 2013 Feb; 15(2):311. PubMed ID: 23314806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Almario CV; Keller MS; Chen M; Lasch K; Ursos L; Shklovskaya J; Melmed GY; Spiegel BMR
    Am J Gastroenterol; 2018 Jan; 113(1):58-71. PubMed ID: 29206816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded table: Some drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2023 Jul; 65(1680):e115-e119. PubMed ID: 37418332
    [No Abstract]   [Full Text] [Related]  

  • 9. Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.
    Stevens BW; Borren NZ; Velonias G; Conway G; Cleland T; Andrews E; Khalili H; Garber JG; Xavier RJ; Yajnik V; Ananthakrishnan AN
    Dig Dis Sci; 2017 Jan; 62(1):197-206. PubMed ID: 27796768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Management of Primary Arterial Hypertension: A Century of Expert Opinions in Cecil Textbook of Medicine.
    Manu P; Rogozea LM; Ivanescu-Lint A; Dan GA
    Am J Ther; 2022 May-Jun 01; 29(3):e287-e297. PubMed ID: 35482399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing pharmacologic management of inflammatory bowel disease.
    Chang S; Hanauer S
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):595-607. PubMed ID: 28475384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice.
    Gisbert JP; Chaparro M
    J Crohns Colitis; 2020 Jun; 14(5):694-709. PubMed ID: 31777929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Table: drugs for ulcerative colitis.
    Med Lett Drugs Ther; 2018 Jul; 60(1550):e114. PubMed ID: 30036353
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological Management of Myasthenia Gravis: A Century of Expert Opinions in Cecil Textbook of Medicine.
    Manu P; Rogozea LM; Roman-Filip C
    Am J Ther; 2021 Nov-Dec 01; 28(6):e631-e637. PubMed ID: 34757964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic therapies in inflammatory bowel disease.
    Cohen LB; Nanau RM; Delzor F; Neuman MG
    Transl Res; 2014 Jun; 163(6):533-56. PubMed ID: 24467968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2018 Jul; 60(1550):107-114. PubMed ID: 30036352
    [No Abstract]   [Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line therapies in inflammatory bowel disease.
    Girardin M; Manz M; Manser C; Biedermann L; Wanner R; Frei P; Safroneeva E; Mottet C; Rogler G; Schoepfer AM
    Digestion; 2012; 86 Suppl 1():6-10. PubMed ID: 23051720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's targeted therapy: myth or real goal?
    Schmidt KJ; Büning J; Jankowiak C; Lehnert H; Fellermann K
    Curr Drug Discov Technol; 2009 Dec; 6(4):290-8. PubMed ID: 20025597
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.